The Future of Dermatology Regulation
A 2025 CNN report reveals that “Elsa,” the FDA’s new generative AI tool designed to accelerate drug approvals, is frequently “hallucinating” by inventing fake studies and citations.
A 2025 CNN report reveals that “Elsa,” the FDA’s new generative AI tool designed to accelerate drug approvals, is frequently “hallucinating” by inventing fake studies and citations.
